Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices 37593 

1We note that the Citizen’s Advisory Panel on 

Medicare Education is also referred to as the 

Advisory Panel on Medicare Education (65 FR 

Continued 

Guidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires Federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. No 

comments were received in response to 

the 60-day comment period. To comply 

with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Disclosure of 

State Rating Requirements; Use: The 

final rule ‘‘Patient Protection and 

Affordable Care Act; Health Insurance 

Market Rules; Rate Review’’ implements 

sections 2701, 2702, and 2703 of the 

Public Health Service Act (PHS Act), as 

added and amended by the Affordable 

Care Act, and sections 1302(e) and 

1312(c) of the Affordable Care Act. The 

rule directs that states submit to CMS 

certain information about state rating 

and risk pooling requirements for their 

individual, small group, and large group 

markets, as applicable. Specifically, 

states will inform CMS of age rating 

ratios that are narrower than 3:1 for 

adults; tobacco use rating ratios that are 

narrower than 1.5:1; a state-established 

uniform age curve; geographic rating 

areas; whether premiums in the small 

and large group market are required to 

be based on average enrollee amounts 

(also known as composite premiums); 

and, in states that do not permit any 

rating variation based on age or tobacco 

use, uniform family tier structures and 

corresponding multipliers. In addition, 

states that elect to merge their 

individual and small group market risk 

pools into a combined pool will notify 

CMS of such election. This information 

will allow CMS to determine whether 

state-specific rules apply or Federal 

default rules apply. It will also support 

the accuracy of the Federal risk 

adjustment methodology. Form Number: 

CMS–10454 (OMB control number: 

0938–1258); Frequency: On Occasion; 

Affected Public: State, Local, or Tribal 

Governments, Private Sector; Number of 

Respondents: 47; Total Annual 

Responses: 47; Total Annual Hours: 

2,239. (For policy questions regarding 

this collection contact Russell Tipps at 

301–492–4371.) 

Dated: August 8, 2017. 

William N. Parham, III, 

Director, Paperwork Reduction Staff Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2017–17020 Filed 8–10–17; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–7046–N] 

Health Insurance MarketplaceSM, 

Medicare, Medicaid, and Children’s 

Health Insurance Programs; Meeting of 

the Advisory Panel on Outreach and 

Education (APOE), September 13, 2017 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces the 

next meeting of the Advisory Panel on 

Outreach and Education (APOE) (the 

Panel) in accordance with the Federal 

Advisory Committee Act. The Panel 

advises and makes recommendations to 

the Secretary of the U.S. Department of 

Health and Human Services (HHS) and 

the Administrator of the Centers for 

Medicare & Medicaid Services (CMS) on 

opportunities to enhance the 

effectiveness of consumer education 

strategies concerning the Health 

Insurance MarketplaceSM, Medicare, 

Medicaid, and the Children’s Health 

Insurance Program (CHIP). This meeting 

is open to the public. 

DATES: Meeting Date: Wednesday, 

September 13, 2017, 8:30 a.m. to 4:00 

p.m. eastern daylight time (e.d.t). 

Deadline for Meeting Registration, 

Presentations, Special Accommodations 

and Comments: Wednesday, August 30, 

2017, 5:00 p.m. (e.d.t.). 

ADDRESSES: Meeting Location: U.S. 

Department of Health & Human 

Services, Hubert H. Humphrey Building, 

200 Independence Avenue SW., Room 

505A, Conference Room, Washington, 

DC 20201. 

Presentations and Written Comments: 

Presentations and written comments 

should be submitted to: Thomas Dudley, 

Designated Federal Official (DFO), 

Office of Communications, Centers for 

Medicare & Medicaid Services, 7500 

Security Boulevard, Mailstop S1–05–06, 

Baltimore, MD 21244–1850 or via email 

at Thomas.Dudley@cms.hhs.gov. 

Registration: The meeting is open to 

the public, but attendance is limited to 

the space available. Persons wishing to 

attend this meeting must register at the 

Web site https://www.regonline.com/ 

apoesept2017meeting or by contacting 

the DFO as listed in the FOR FURTHER

INFORMATION CONTACT section of this 

notice, by the date listed in the DATES

section of this notice. Individuals 

requiring sign language interpretation or 

other special accommodations should 

contact the DFO at the address listed in 

the ADDRESSES section of this notice by 

the date listed in the DATES section of 

this notice. 

FOR FURTHER INFORMATION CONTACT: 

Thomas Dudley, Designated Federal 

Official, Office of Communications, 

CMS, 7500 Security Boulevard, Mail 

Stop S1–05–06, Baltimore, MD 21244– 

1850, 410–786–1442, email 

Thomas.Dudley@cms.hhs.gov. 

Additional information about the APOE 

is available on the Internet at: http://

www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html. 

Press inquiries are handled through the 

CMS Press Office at (202) 690–6145. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The Advisory Panel for Outreach and 

Education (APOE) (the Panel) is 

governed by the provisions of Federal 

Advisory Committee Act (FACA) (Pub. 

L. 92–463), as amended (5 U.S.C. App. 

2), which sets forth standards for the 

formation and use of federal advisory 

committees. The Panel is authorized by 

section 1114(f) of the Social Security 

Act (42 U.S.C. 1314(f)) and section 222 

of the Public Health Service Act (42 

U.S.C. 217a). 

The Secretary of the U.S. Department 

of Health and Human Services (HHS) 

(the Secretary) signed the charter 

establishing the Citizen’s Advisory 

Panel on Medicare Education 1 (the 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
37594 Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices 

4617). The name was updated in the Second 

Amended Charter approved on July 24, 2000. 

2Health Insurance MarketplaceSM and 

MarketplaceSM are service marks of the U.S. 

Department of Health & Human Services. 

predecessor to the APOE) on January 21, 

1999 (64 FR 7899, February 17, 1999) to 

advise and make recommendations to 

the Secretary and the Administrator of 

the Centers for Medicare & Medicaid 

Services (CMS) on the effective 

implementation of national Medicare 

education programs, including with 

respect to the Medicare+Choice (M+C) 

program added by the Balanced Budget 

Act of 1997 (Pub. L. 105–33). 

The Medicare Modernization Act of 

2003 (MMA) (Pub. L. 108–173) 

expanded the existing health plan 

options and benefits available under the 

M+C program and renamed it the 

Medicare Advantage (MA) program. We 

have had substantial responsibilities to 

provide information to Medicare 

beneficiaries about the range of health 

plan options available and better tools 

to evaluate these options. The 

successful MA program implementation 

required CMS to consider the views and 

policy input from a variety of private 

sector constituents and to develop a 

broad range of public-private 

partnerships. 

In addition, Title I of the MMA 

authorized the Secretary and the 

Administrator of CMS (by delegation) to 

establish the Medicare prescription drug 

benefit. The drug benefit allows 

beneficiaries to obtain qualified 

prescription drug coverage. In order to 

effectively administer the MA program 

and the Medicare prescription drug 

benefit, we have substantial 

responsibilities to provide information 

to Medicare beneficiaries about the 

range of health plan options and 

benefits available, and to develop better 

tools to evaluate these plans and 

benefits. 

The Affordable Care Act (Patient 

Protection and Affordable Care Act, 

Public Law 111–148, and Health Care 

and Education Reconciliation Act of 

2010, Public Law 111–152) expanded 

the availability of other options for 

health care coverage and enacted a 

number of changes to Medicare as well 

as to Medicaid and the Children’s 

Health Insurance Program (CHIP). 

Qualified individuals and qualified 

employers are now able to purchase 

private health insurance coverage 

through a competitive marketplace, 

called an Affordable Insurance 

Exchange (also called Health Insurance 

MarketplaceSM,2 or MarketplaceSM). In 

order to effectively implement and 

administer these changes, we must 

provide information to consumers, 

providers, and other stakeholders 

through education and outreach 

programs regarding how existing 

programs will change and the expanded 

range of health coverage options 

available, including private health 

insurance coverage through the 

MarketplaceSM. The APOE allows us to 

consider a broad range of views and 

information from interested audiences 

in connection with this effort and to 

identify opportunities to enhance the 

effectiveness of education strategies 

concerning the Affordable Care Act. 

The scope of this panel also includes 

advising on issues pertaining to the 

education of providers and stakeholders 

with respect to the Affordable Care Act 

and certain provisions of the Health 

Information Technology for Economic 

and Clinical Health (HITECH) Act 

enacted as part of the American 

Recovery and Reinvestment Act of 2009 

(ARRA). 

On January 21, 2011, the Panel’s 

charter was renewed and the Panel was 

renamed the Advisory Panel for 

Outreach and Education. The Panel’s 

charter was most recently renewed on 

January 19, 2017, and will terminate on 

January 19, 2019 unless renewed by 

appropriate action. 

Under the current charter, the APOE 

will advise the Secretary and the 

Administrator on optimal strategies for 

the following: 

• Developing and implementing 

education and outreach programs for 

individuals enrolled in, or eligible for, 

Medicare, Medicaid, and the Children’s 

Health Insurance Program (CHIP), or 

coverage available through the Health 

Insurance MarketplaceSM and other 

CMS programs. 

• Enhancing the federal government’s 

effectiveness in informing Health 

Insurance MarketplaceSM, Medicare, 

Medicaid, and CHIP consumers, issuers, 

providers, and stakeholders, through 

education and outreach programs, on 

issues regarding these programs, 

including the appropriate use of publicprivate partnerships to leverage the 

resources of the private sector in 

educating beneficiaries, providers, and 

stakeholders. 

• Expanding outreach to vulnerable 

and underserved communities, 

including racial and ethnic minorities, 

in the context of Health Insurance 

MarketplaceSM, Medicare, Medicaid, 

and CHIP education programs and other 

CMS programs as designated. 

• Assembling and sharing an 

information base of ‘‘best practices’’ for 

helping consumers evaluate health 

coverage options. 

• Building and leveraging existing 

community infrastructures for 

information, counseling, and assistance. 

• Drawing the program link between 

outreach and education, promoting 

consumer understanding of health care 

coverage choices, and facilitating 

consumer selection/enrollment, which 

in turn support the overarching goal of 

improved access to quality care, 

including prevention services, 

envisioned under the Affordable Care 

Act. 

The current members of the Panel are: 

Kellan Baker, Associate Director, Center 

for American Progress; Robert Blancato, 

President, Matz, Blancato & Associates; 

Dale Blasier, Professor of Orthopaedic 

Surgery, Department of Orthopaedics, 

Arkansas Children’s Hospital; Deborah 

Britt, Executive Director of Community 

& Public Relations, Piedmont Fayette 

Hospital; Deena Chisolm, Associate 

Professor of Pediatrics & Public Health, 

The Ohio State University, Nationwide 

Children’s Hospital; Josephine DeLeon, 

Director, Anti-Poverty Initiatives, 

Catholic Charities of California; Robert 

Espinoza, Vice President of Policy, 

Paraprofessional Healthcare Institute; 

Louise Scherer Knight, Director, The 

Sidney Kimmel Comprehensive Cancer 

Center at Johns Hopkins; Roanne 

Osborne-Gaskin, M.D., Senior Medical 

Director, MDWise, Inc.; Cathy Phan, 

Outreach and Education Coordinator, 

Asian American Health Coalition DBA 

HOPE Clinic; Kamilah Pickett, 

Litigation Support, Independent 

Contractor; Brendan Riley, Outreach 

and Enrollment Coordinator, NC 

Community Health Center Association; 

Alvia Siddiqi, Medicaid Managed Care 

Community Network (MCCN) Medical 

Director, Advocate Physician Partners, 

Carla Smith, Executive Vice President, 

Healthcare Information and 

Management Systems Society (HIMSS); 

Tobin Van Ostern, Vice President and 

Co-Founder, Young Invincibles 

Advisors; and Paula Villescaz, Senior 

Consultant, Assembly Health 

Committee, California State Legislature. 

II. Provisions of This Notice 

In accordance with section 10(a) of 

the FACA, this notice announces a 

meeting of the APOE. The agenda for 

the September 13, 2017 meeting will 

include the following: 

• Welcome and listening session with 

CMS leadership 

• Recap of the previous (March 22, 

2017) meeting 

• Review CMS programs and initiatives 

• Provide an opportunity for public 

comment 

• Summarize the meeting and review 

recommendations and next steps 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices 37595 

Individuals or organizations that wish 

to make a 5-minute oral presentation on 

an agenda topic should submit a written 

copy of the oral presentation to the DFO 

at the address listed in the ADDRESSES

section of this notice by the date listed 

in the DATES section of this notice. The 

number of oral presentations may be 

limited by the time available. 

Individuals not wishing to make an oral 

presentation may submit written 

comments to the DFO at the address 

listed in the ADDRESSES section of this 

notice by the date listed in the DATES

section of this notice. 

III. Security and Building 

The meeting is open to the public, but 

attendance is limited to the space 

available. Persons wishing to attend this 

meeting must register by contacting the 

DFO at the address listed in the 

ADDRESSES section of this notice or by 

telephone at the number listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice by the date 

specified in the DATES section of this 

notice. 

Since this meeting will be held in a 

Federal Government Building, the 

Hubert H. Humphrey Building, Federal 

security measures are applicable. In 

planning your arrival time, we 

recommend allowing additional time to 

clear security. To gain access to the 

building, participants will be required 

to show a government-issued photo 

identification (for example, driver’s 

license or passport), and must be listed 

on an approved security list before 

persons are permitted entrance. Persons 

not registered in advance will not be 

permitted into the Hubert H. Humphrey 

Building and will not be permitted to 

attend the Panel meeting. 

All persons entering the building 

must pass through a metal detector. In 

addition, all items brought to the Hubert 

H. Humphrey Building, whether 

personal or for the purpose of 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for the purpose 

of presentation. 

Authority: 42 U.S.C. 217a, sec. 222 of the 

Public Health Service Act, as amended; 42 

U.S.C. 1314(f), sec. 1114(f) of the Social 

Security Act; and Public Law 92–463, as 

amended (5 U.S.C. App. 2). 

Dated: August 2, 2017. 

Seema Verma, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 2017–16979 Filed 8–10–17; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Macula 

Degenerative Diseases 

Date: August 23, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Nataliya Gordiyenko, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7846, Bethesda, MD 20892, 

301.435.1265, gordiyenkon@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 7, 2017. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–16914 Filed 8–10–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Muscular Dystrophy 

Coordinating Committee (MDCC). 

The meeting will be open to the 

public and accessible by live webcast. 

Attendance is limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Muscular Dystrophy 

Coordinating Committee. 

Type of meeting: Open Meeting. 

Date: October 4, 2017. 

Time: 8:30 a.m. to 4:30 p.m. *Eastern 

Time*—Approximate end time. 

Agenda: Agenda: The purpose of this 

meeting is to bring together committee 

members, representing government agencies, 

patient advocacy groups, other voluntary 

health organizations, and patients and their 

families to update one another on progress 

relevant to the Action Plan for the Muscular 

Dystrophies and to coordinate activities and 

discuss gaps and opportunities leading to 

better understanding of the muscular 

dystrophies, advances in treatments, and 

improvements in patients’ and their families’ 

lives. Prior to the meeting, an agenda will be 

posted to the MDCC meeting registration Web 

site: https://meetings.ninds.nih.gov/ 

meetings/Oct42017/. 

Registration: To register, please go to: 

https://meetings.ninds.nih.gov/meetings/ 

Oct42017/. 

Webcast Live: For those not able to attend 

in person, this meeting will be webcast at: 

http://videocast.nih.gov/. 

Place: Neuroscience Center, Conference 

Room C/D, 6001 Executive Boulevard, 

Rockville, Maryland 20852. 

Contact Person: Glen H. Nuckolls, Ph.D., 

Executive Secretary, Muscular Dystrophy 

Coordinating Committee, National Institute 

of Neurological Disorders and Stroke, NIH, 

6001 Executive Boulevard, NSC 2203, 

Bethesda, MD 20892, (301) 496–5745, 

glen.nuckolls@ninds.nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

All visitors must go through a security 

check at the building entrance to receive a 

visitor’s badge. A government issued photo 

ID is required. Further information can be 

found at the registration Web site: https://

meetings.ninds.nih.gov/meetings/Oct42017/. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 


asabaliauskas on DSKBBXCHB2PROD with NOTICES